DENTSPLY International (NASDAQ:XRAY) had an volatile session and gained 1.12 points till last call. The price was at $64.73, gaining 1.76% till the last intraday data. The total uptick value was $27 million while the total downtick value was $35.38 million. The shares saw a net money flow of $(-8.38) million and the up/down ratio stood at 0.76. The stock has seen a change of of 3.32% for the week. The share had a block transaction during the course of trading in which the net money flow was $(-6.71) million. Almost $1.08 million were received in upticks and approximately $7.79 million were lost in downticks, thereby giving the up/down ratio of 0.14.
Currently the company Insiders own 2.2% of DENTSPLY International shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -16.44% . Institutional Investors own 95.23% of DENTSPLY International shares. During last six month period, the net percent change held by insiders has seen a change of -16.44%. On the companys insider trading activities, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the (Exec VP, Mfg & Supply Chain) of Dentsply Sirona Inc., Berthan Rainer had sold 6,464 shares worth of $404,388 in a transaction dated June 2, 2016. In this transaction, 6,464 shares were sold at $62.56 per share.
DENTSPLY International (NASDAQ:XRAY) : On Monday heightened volatility was witnessed in DENTSPLY International (NASDAQ:XRAY) which led to swings in the share price. The stock opened for trading at $64.22 and hit $65.83 on the upside , eventually ending the session at $64.73, with a gain of 1.76% or 1.12 points. The heightened volatility saw the trading volume jump to 2,704,824 shares. The 52-week high of the share price is $65.83 and the company has a market cap of $15,162 million. The 52-week low of the share price is at $49.48 .
Many analysts have stated their opinion on the company shares. Morgan Stanley downgrades its view on DENTSPLY International (NASDAQ:XRAY) according to the research report released by the firm to its investors. The shares have now been rated Equal-weight by the stock experts at the ratings house. Earlier, the shares had a rating of Overweight. Morgan Stanley maintains the current price target of $65 per share on DENTSPLY International . The rating by the firm was issued on March 24, 2016.
DENTSPLY International Inc. is a designer, developer, manufacturer and marketer of a range of consumable dental products for the professional dental market. It operates through three segments: Dental Consumable and Certain International Businesses; Dental Specialty and Laboratory and Certain Global Distribution Businesses, and Healthcare and Emerging Markets Businesses. All the segments are primarily engaged in the design, manufacture and distribution of dental and medical products in four product categories. Its Dental Consumable Products consist of dental supplies and devices and small equipment used in dental offices. Its Dental Laboratory Products are used in the preparation of dental appliances by dental laboratories. Its Dental Specialty Products are specialized treatment products used within the dental office and laboratory settings. Its Consumable Medical Device Products consist mainly of urology catheters, certain surgical products, medical drills and other products.